What this study is
This clinical trial develops and tests how well a multi-level intervention (MLI), The Ohio State University (OSU) SCREEN Community Program, works to increase screening and follow-up for breast, cervical and colorectal (CRC) cancer among low-income and un/underinsured female residents in three counties in Central Ohio. In Ohio, incidence and mortality rates for breast, cervical and CRC are higher than or similar to the national average; in addition, underserved populations - minority, rural and low-income women - have higher rates of these cancers. Screening can detect precancerous colorectal and cervical lesions and other early-stage cancers when treatment is less intensive and more successful and is known to reduce mortality rates for breast, cervical, and CRC, however many of these women lack access to health care and screenings. This MLI includes clinic-based components, such as patient education, as well as community-based strategies, such as media programs and training health workers, that can increase rates of guideline-recommended breast, cervical and CRC screening and follow-ups in underserved populations. The OSU SCREEN Community Program may be an effective way to improve breast, cervical and CRC screenings among underserved women in Ohio.
What's being tested
- Cancer Screening
Intervention · OTHER
Undergo cancer screening
- Discussion
Intervention · OTHER
Participate in discussions
- Educational Activity
Intervention · OTHER
Receive coaching calls
- Educational Intervention
Intervention · OTHER
Receive educational materials
- Focus Group
Intervention · BEHAVIORAL
Participate in focus group
- Health Care Delivery
Intervention · OTHER
Integrate new activities into usual clinic processes
- Health Promotion
Intervention · OTHER
Promote screening and wellness visits
- Health Promotion and Education
Intervention · OTHER
Participate in educational sessions
- Health Promotion and Education
Intervention · OTHER
Participate in early wave MLI
- Health Promotion and Education
Intervention · OTHER
Participate in late wave MLI
- Health Risk Assessment
Intervention · BEHAVIORAL
Incorporate risk assessments
- Implementation
Intervention · PROCEDURE
Implement MLI
- Informational Intervention
Intervention · OTHER
Review MLI materials
- Internet-Based Intervention
Intervention · OTHER
Receive educational online materials
- Interview
Intervention · OTHER
Participate in interview
- Outreach
Intervention · BEHAVIORAL
Receive outreach activities
- Patient Navigation
Intervention · BEHAVIORAL
Receive access to CHW
- Survey Administration
Intervention · OTHER
Ancillary studies
Study details
- Official title
- A Multi-Level Intervention for Improving Screening Rates of Breast, Cervical and Colorectal Cancer in Women in Low-Income Communities
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Conditions
- Breast Carcinoma · Cervical Carcinoma · Colorectal Carcinoma
- Enrolling
- 2,067 people
- Starts
- 2024-03-12
- Est. completion
- 2029-12-31
- Design
- Open-label, randomized, sequential groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Sex ALLHealthy volunteers AcceptedYou may qualify if
- Level 1 is the health clinics (Helping Hands [pilot]; 6 Lower Lights clinics). Clinics are eligible if they provide preventive health care to residents of the targeted census tracts.
- Level 2 focuses on health care providers (physicians, nurses, physician assistants [PA]/nurse practitioners [NPs]) and office staff practicing at participating clinics who are involved in the screening and/or screening referral process (determined by individual clinical sites) and can speak, read, and write English
- Patients (Level 3) are the recipients of health care and screening interventional strategies implemented by clinics and providers.
- Level 4 is the community to include residents in targeted census tracts around each clinic.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openOhio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Electra D. Paskett, PhD · Contact614-293-3917Electra.Paskett@osumc.edu
- Electra D. Paskett · Principal investigator
Recruiting
Study team
Sponsor
Ohio State University Comprehensive Cancer Center
Study ID OSU-23400
Principal investigator
Electra D Paskett, PhD
Ohio State University Comprehensive Cancer Center
CONTACT
The Ohio State University Comprehensive Cancer Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.